Clinical Trial Update: A Comparison of Nab-PHP and TCbHP Efficacy in Neoadjuvant Therapy for HER2-positive Early Breast Cancer [Phase 3]

View source ↗

Summary

Phase 3 neoadjuvant trial comparing nab-paclitaxel–based therapy (Nab-PHP) with a taxane-based regimen (TCbHP) for HER2-positive early breast cancer; recruitmen…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• Nab-paclitaxel (paclitaxel protein-bound)
• PACLITAXEL (PACLITAXEL)
• Pertuzumab (pertuzumab)
• Trastuzumab (trastuzumab)

Snippet

Sponsor: Henan Cancer Hospital | Conditions: Breast Cancer,HER2-positive | Phase 3 | Status: RECRUITING